Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Insider Sells $36,614.40 in Stock

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Free Report) insider Camille L. Bedrosian sold 11,442 shares of the stock in a transaction on Monday, September 30th. The stock was sold at an average price of $3.20, for a total value of $36,614.40. Following the transaction, the insider now directly owns 143,801 shares in the company, valued […]

Leave a Reply

Your email address will not be published.

Previous post Nektar Therapeutics (NASDAQ:NKTR) Rating Reiterated by BTIG Research
Next post Citigroup Boosts Baxter International (NYSE:BAX) Price Target to $40.00